Intellipharmaceutics International, Inc.
(Toronto Stock Exchange : IPCI)

( )
IPCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.42%149.000.0%$1844.43m
NVAXNovavax, Inc. -1.34%218.5392.9%$1366.38m
OCGNOcugen, Inc. -8.00%7.360.0%$794.02m
AMGNAmgen, Inc. 0.00%227.521.3%$600.44m
ILMNIllumina, Inc. -0.19%445.003.5%$553.92m
REGNRegeneron Pharmaceuticals, Inc. -0.26%452.002.7%$530.23m
VRTXVertex Pharmaceuticals, Inc. -0.23%212.501.9%$509.68m
GILDGilead Sciences, Inc. 0.00%62.791.0%$494.89m
ALXNAlexion Pharmaceuticals, Inc. -0.24%153.282.0%$384.03m
BIIBBiogen, Inc. -0.20%276.721.7%$379.72m
BNGOBioNano Genomics, Inc. -7.29%9.290.0%$376.98m
CRSPCRISPR Therapeutics AG -2.65%123.910.6%$293.95m
EXASEXACT Sciences Corp. 0.00%131.3018.4%$246.20m
SRNESorrento Therapeutics, Inc. -1.19%10.001.3%$236.90m
VXRTVaxart, Inc. -4.80%7.140.0%$213.34m

Company Profile

Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.